ESC Premium Access

Evaluation of VTE-BLEED for predicting intracranial or fatal bleedings in stable anticoagulated patients with venous thromboembolism


About the speaker

Doctor Erik Klok

Leiden University Medical Centre, Leiden (Netherlands (The))
3 presentations
0 follower

6 more presentations in this session

Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)


Sex differences in the clinical characteristics and outcomes of patients with venous thromboembolism: from the COMMAND VTE Registry

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)


Short-term versus indefinite anticoagulant therapy for secondary prevention of unprovoked venous thromboembolism: a decision analysis

Speaker: Mr F. Khan (Ottawa, CA)


"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism: D-Dimer inter-assay concordance

Speaker: Mr F. Khan (Ottawa, CA)


Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry

Speaker: Professor N. Meneveau (Besancon, FR)


Access the full session

Venous thrombosis and anticoagulation

Speakers: Doctor E. Klok, Doctor A. Kalayci Karabay, Doctor Y. Yoshikawa, Mr F. Khan, Mr F. Khan...

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk